Cellebrite Di LTD

Thomas E. Hogan, Chief Executive Officer and a Director of Cellebrite DI Ltd., sold 139,713 shares of common stock on August 11, 2026 for $15.39 per share.

Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd., sold 411 shares of common stock on August 12, 2026 for $16.07 per share.

David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., sold 230 shares of common stock on August 12, 2026 for $16.07 per share.

Cellebrite's Chief Financial Officer, David Barter, disposed of 41,734 ordinary shares to cover tax obligations related to vested restricted stock units.

Cellebrite CEO Thomas E. Hogan reported the sale of 103,188 ordinary shares to cover tax withholding obligations related to the vesting of restricted stock units.

Cellebrite Chief Marketing Officer David Gee sold company shares to cover tax liabilities related to vested restricted stock units, as disclosed in a Form 4 filing.

True Wind Capital and its affiliates have filed an Amendment No. 3 to their Schedule 13D, updating their beneficial ownership in Cellebrite DI Ltd. to 5.8% of outstanding Ordinary Shares.

SUNCORPORATION has filed an amendment to its Schedule 13G, confirming its beneficial ownership of 42.67% of Cellebrite DI Ltd.'s ordinary shares.

FMR LLC and Abigail P. Johnson have disclosed a reduction in their passive beneficial ownership stake in Cellebrite DI Ltd. to 4.1% of common stock as of March 31, 2025.

FMR LLC, the parent company of Fidelity Investments, has disclosed a 5.2% beneficial ownership stake in Cellebrite DI Ltd. as of December 31, 2024, held in the ordinary course of business.

An investment group, including IGP Saferworld and IGP Investments (G.P.L.P), has fully divested its beneficial ownership in Cellebrite DI Ltd. by December 31, 2024, while managing director Haim Shani retains a small individual holding.

SUNCORPORATION has reported a beneficial ownership of 43.7% of Cellebrite DI Ltd.'s ordinary shares, totaling 102,576,122 shares, as of December 31, 2024.